| Literature DB >> 35210361 |
Meng Liu1,2, Gangqiang Guo1,2,3, Pengge Qian4, Jianbing Mu5, Binbin Lu3, Xiaoqin He6, Yanting Fan3, Xiaomin Shang3, Guang Yang1,2, Shijun Shen1,2, Wenju Liu1,2, Liping Wang1,2, Liang Gu1,2, Quankai Mu7, Xinyu Yu6, Yuemeng Zhao3,8, Richard Culleton9,10, Jun Cao6, Lubin Jiang8, Thomas E Wellems11, Jing Yuan12, Cizhong Jiang13,2, Qingfeng Zhang14.
Abstract
5-methylcytosine (m5C) is an important epitranscriptomic modification involved in messenger RNA (mRNA) stability and translation efficiency in various biological processes. However, it remains unclear if m5C modification contributes to the dynamic regulation of the transcriptome during the developmental cycles of Plasmodium parasites. Here, we characterize the landscape of m5C mRNA modifications at single nucleotide resolution in the asexual replication stages and gametocyte sexual stages of rodent (Plasmodium yoelii) and human (Plasmodium falciparum) malaria parasites. While different representations of m5C-modified mRNAs are associated with the different stages, the abundance of the m5C marker is strikingly enhanced in the transcriptomes of gametocytes. Our results show that m5C modifications confer stability to the Plasmodium transcripts and that a Plasmodium ortholog of NSUN2 is a major mRNA m5C methyltransferase in malaria parasites. Upon knockout of P. yoelii nsun2 (pynsun2), marked reductions of m5C modification were observed in a panel of gametocytogenesis-associated transcripts. These reductions correlated with impaired gametocyte production in the knockout rodent malaria parasites. Restoration of the nsun2 gene in the knockout parasites rescued the gametocyte production phenotype as well as m5C modification of the gametocytogenesis-associated transcripts. Together with the mRNA m5C profiles for two species of Plasmodium, our findings demonstrate a major role for NSUN2-mediated m5C modifications in mRNA transcript stability and sexual differentiation in malaria parasites.Entities:
Keywords: RNA bisulfite sequencing; RNA methyltransferase; epitranscriptomic modifications; gametocytogenesis; gene knockout
Mesh:
Substances:
Year: 2022 PMID: 35210361 PMCID: PMC8892369 DOI: 10.1073/pnas.2110713119
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 12.779
Fig. 1.Features of m5C-modified mRNA in malaria parasites. (A) Dot blot assays show detection of m5C modifications in schizont-stage mRNAs (enriched from total RNA) from P. falciparum and P. yoelii. m5C-modified and unmodified RNA oligonucleotides served as positive and negative controls, respectively. (B) LC-MS/MS signals indicating modified nucleotides from P. yoelii schizont-stage mRNA. Am, 2′-O-methyladenosine; Cm, 2′-O-methylcytosine; Gm, 2′-O-methylguanosine; hm5C, 5-Hydroxymethylcytosine; m5C, 5-methylcytosine; m5U, 5-methyluridine; m6A, N6-methyladenosine; m7G, N7-methyl-2′-guanosine; rA, adenosine; rC, cytosine; rG, guanosine; rU, uracil. (C) Frequency logo displays of the nucleotides proximal to mRNA m5C sites in the schizonts (S) and gametocytes (G) of P. yoelii (Py), and the schizonts (S) and stage III, IV, and V gametocytes (GIII, GIV, GV) of P. falciparum (Pf). (D) Density distribution of the m5C sites in mRNA transcripts of P. yoelii and P. falciparum. The moving averages (10-bp window) of percentage mRNA cytosine content (light blue) are lower in the 5′ and 3′ UTR regions than in the CDS, as expected for these species. (E) Integrative Genomics Viewer displays of example transcript sequence levels and their m5C sites from genes in P. yoelii (Left) and P. falciparum (Right). Vertical red bars indicate the m5C levels detected in specific parasite stages. The m5C levels were normalized to their corresponding transcript fragment abundance levels before comparison.
Gene ontology (GO) assignments for m5C-modified transcripts in schizonts and gametocytes of P. yoelii and P. falciparum
| ID | Biological processes | Result count | Stage | |
| GO:0007049 | Cell cycle | 5 | 9.12E-03 | Py.S |
| GO:0015698 | Inorganic anion transport | 2 | 1.18E-02 | Py.S |
| GO:0090304 | Nucleic acid metabolic process | 49 | 1.99E-02 | Py.S |
| GO:0006352 | DNA-templated transcription, initiation | 4 | 4.45E-02 | Py.S |
| GO:0006720 | Isoprenoid metabolic process | 3 | 4.73E-02 | Py.S |
| GO:0016310 | Phosphorylation | 28 | 9.44E-04 | Py.G |
| GO:0006796 | Phosphate-containing compound metabolic process | 46 | 1.31E-03 | Py.G |
| GO:0009166 | Nucleotide catabolic process | 7 | 2.20E-03 | Py.G |
| GO:0046031 | ADP metabolic process | 6 | 2.27E-03 | Py.G |
| GO:0046939 | Nucleotide phosphorylation | 6 | 7.41E-03 | Py.G |
| GO:0006468 | Protein phosphorylation | 21 | 1.24E-02 | Py.G |
| GO:GNF0004 | Sexual development | 78 | 1.48E-08 | Py.G |
| GO:0006325 | Chromatin organization | 5 | 6.59E-03 | Pf.S |
| GO:0043543 | Protein acylation | 4 | 7.73E-03 | Pf.S |
| GO:0000280 | Nuclear division | 3 | 2.06E-03 | Pf.S |
| GO:0015858 | Nucleoside transport | 2 | 4.82E-03 | Pf.S |
| GO:0031365 | N-terminal protein amino acid modification | 2 | 9.38E-03 | Pf.S |
| GO:0015858 | Nucleoside transport | 3 | 4.94E-04 | Pf.GIII |
| GO:0009987 | Cellular process | 159 | 1.18E-03 | Pf.GIII |
| GO:0031365 | N-terminal protein amino acid modification | 3 | 1.86E-03 | Pf.GIII |
| GO:0006325 | Chromatin organization | 8 | 1.78E-03 | Pf.GIII |
| GO:1901642 | Nucleoside transmembrane transport | 2 | 6.26E-03 | Pf.GIII |
| GO:0008152 | Metabolic process | 140 | 4.68E-03 | Pf.GIII |
| GO:0042273 | Ribosomal large subunit biogenesis | 5 | 8.46E-03 | Pf.GIII |
| GO:0007155 | Cell adhesion | 9 | 1.65E-03 | Pf.GIV |
| GO:0006811 | Ion transport | 9 | 9.05E-03 | Pf.GIV |
| GO:0048870 | Cell motility | 6 | 4.01E-03 | Pf.GV |
| GO:0051674 | Localization of cell | 6 | 4.01E-03 | Pf.GV |
| GO:0000737 | DNA catabolic process, endonucleolytic | 2 | 5.92E-03 | Pf.GV |
| GO:0006415 | Translational termination | 3 | 7.60E-03 | Pf.GV |
| GO:0043624 | Cellular protein complex disassembly | 3 | 7.60E-03 | Pf.GV |
| GO:GNF0004 | Sexual development | 43 | 2.76E-05 | Pf.GV |
Fig. 2.Association of m5C methylation levels with transcript longevity and protein expression in gametocytes. (A and B) Heatmaps indicate the expression of transcripts whose levels are greater than or equal to threefold higher in gametocytes than in schizonts of P. yoelii and P. falciparum. Boxplots show corresponding m5C levels of those genes at different stages (***P < 0.001, Wilcoxon test). The m5C levels were normalized to their corresponding transcript fragment abundance levels before comparison. (C) Boxplot and cumulative fraction plots indicate the longer mRNA half-lives of m5C methylated (red) relative to nonmethylated (blue) transcripts in P. yoelii gametocytes (***P < 0.001, Wilcoxon test). (D) Boxplot and cumulative fraction plots compare the levels of proteins translated from m5C-methylated (red) and nonmethylated (blue) transcripts in P. yoelii gametocytes (***P < 0.001, Wilcoxon test).
Fig. 3.Identification and verification of PyNSUN2 as a m5C methyltransferase. (A) Phylogenetic analysis of candidate NSUN m5C methyltransferases in P. yoelii and P. falciparum. Sequences were aligned using ClustalX 2.1. The neighbor-joining phylogeny was performed using MEGA 5.2.2 with 1,000 replicates. (B) Strategies to generate Pynsun2-KO and Pfnsun2-KO parasites. For CRISPR/Cas9-mediated deletion of the Pynsun2 CDS, the left arm (LA) and right arm (RA) were designed to match sequences in the 5′ UTR and 3′ UTR of Pynsun2, respectively. For disruption of Pfnsun2, sgRNA targeting was used to delete a portion of the CDS (red box) and introduce multiple stop codons downstream. Red thunderbolt indicates the site for sgRNA targeting. PCR products with indicated primer pairs confirmed the expected differences between the WT and allelically manipulated parasites (single clones: sc1–3, with the expected amplicon sizes; p5/p6: 1.1 kb for the Pynsun2-KO vs. 2.7 kb for WT parasites; p7/p8: 1 kb for Pynsun2-KO vs. 2.6 kb for WT). Sequence data confirming the deletion and stop codons in the Pfnsun2-KO parasites are shown in . (C) Summary results from experiments to disrupt homologs of the NSUN family in P. yoelii and P. falciparum. NT: not tested. Heatmaps show transcript fragment abundance levels from each gene in the WT parasites, as determined by RNA-seq. (D) LC-MS/MS-determined levels of m5C/C in the poly(A)-selected transcripts of P. yoelii WT and Pynsun2-KO parasites (schizont stage). Paired points represent the results of each of two biological replicates showing an average 72% reduction (P = 0.046 by paired t test). (E) Histogram shows numbers of mRNA m5C sites in schizont stages of WT, Pynsun2-KO and Pynsun2-KO-RC P. yoelii clones. Box plot shows the corresponding m5C levels in WT, Pynsun2-KO, and Pynsun2-KO-RC lines (Right) (***P < 0.001, Wilcoxon test). Only m5C sites detected in both replicates were used for the graphs. (F) Strategy for genetic complementation repair of the Pynsun2-KO with the gene CDS fused with a C-terminal 6HA. (Upper) The design for the CRISPR/Cas9-mediated gene knockin. LA and RA match sequences in the 5′ UTR and 3′ UTR of Pynsun2, respectively. Red thunderbolt indicates the site for sgRNA targeting. (Lower) The expected PCR products from three Pynsun2-KO-RC clones (sc1–3) by the primer sets p5/p6 (1.1 kb for the Pynsun2-KO line vs. 2.7 kb for the WT and Pynsun2-KO-RC lines) and p7/p8 (1 kb for the Pynsun2-KO vs. 2.6 kb for the WT and Pynsun2-KO-RC lines).
Fig. 4.Reduction of gametocytogenesis in Plasmodium NSUN2 KO lines and its restoration by gene complementation. (A) Gametocytogenesis is markedly decreased in Pynsun2-KO and Pfnsun2-KO parasites relative to high levels in the original WT lines. Repair of the KO in Pynsun2-KO parasites restores gametocyte production. Error bars represent median and 95% confidence intervals (CI) (***P < 0.001; **P < 0.01; N.S.: not significant, Wilcoxon test). (B) No significant effect on gametocyte production was detected after knockout of the Pynsun1 gene. Error bars represent median and 95% CIs (N.S.: no significant difference, Wilcoxon test). (C) Markedly decreased ookinete conversion rate in Pynsun2-KO relative to WT parasites as well as Pynsun2-KO-RC parasites carrying the restored gene. Data were obtained from two independent replicates. Error bars represent median and 95% CIs (***P < 0.001; N.S.: not significant, Wilcoxon test). (D) Number of oocysts in mosquito midguts 7 d after blood feeding with WT or Pynsun2-KO gametocytes (Left), and number of sporozoites in mosquito salivary glands 14 d after blood feeding in the same experiments (Right). The number of mosquitoes dissected in each group is indicated. Medians and 95% CIs are indicated (****P < 0.0001, Wilcoxon test). (E) Identification of transcripts that are differentially expressed between Pynsun2-KO and WT parasites at the schizont stage. Transcripts that were found to have greater than or equal to threefold higher or lower levels in Pynsun2-KO vs. WT parasites are marked in red or blue, respectively. (F) Higher or lower levels of transcripts in the KO clone are reversed by restoration of Pynsun2 expression in the Pynsun2-KO-RC clone (***P < 0.001, Wilcoxon test).